PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
Treatment of Neutropenic Patients With Fever Who Are Suspected to Have A Gram Positive Infection
- First Posted Date
- 2002-05-06
- Last Posted Date
- 2009-12-01
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 120
- Registration Number
- NCT00035425
- Locations
Pfizer Investigational Site
Study of the Efficacy of an Investigational Drug in Adult Patients With Non Small-Cell Lung Cancer (NSCLC)
- Conditions
- Carcinoma, Non-Small-Cell LungLung Neoplasms
- First Posted Date
- 2002-05-03
- Last Posted Date
- 2012-02-16
- Lead Sponsor
- Pfizer
- Registration Number
- NCT00034957
- Locations
- 🇺🇸
Research Center, Dallas, Texas, United States
New Antibiotic to Treat Patients With Community-acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia)
- Conditions
- Pneumonia, PneumococcalCommunity Acquired InfectionsGram-positive Bacterial Infections
- First Posted Date
- 2002-05-03
- Last Posted Date
- 2011-04-26
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 230
- Registration Number
- NCT00035269
- Locations
- 🇨🇳
Research Center, Taoyuan, Taiwan
A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer
- Conditions
- Colorectal NeoplasmsBreast NeoplasmsCarcinoma, Non-Small-Cell LungPancreatic Neoplasms
- First Posted Date
- 2002-05-03
- Last Posted Date
- 2007-05-04
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 172
- Registration Number
- NCT00034827
- Locations
- 🇺🇸
Pfizer Investigational Site, Cincinnati, Ohio, United States
Safety And Efficacy Study Of The Combination Of CpG 7909 And Herceptin In Patients With Metastatic Breast Cancer
- First Posted Date
- 2002-03-01
- Last Posted Date
- 2011-05-30
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 12
- Registration Number
- NCT00031278
- Locations
- 🇺🇸
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸Fletcher Allen Health Care, Burlington, Vermont, United States
🇺🇸Univ. of Connecticut Health Center, Farmington, Connecticut, United States
An Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis
- Conditions
- Meningitis, CryptococcalHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Pfizer
- Registration Number
- NCT00002077
- Locations
- 🇺🇸
Cook County Hosp, Chicago, Illinois, United States
🇺🇸Saint Michael's Med Ctr, Newark, New Jersey, United States
🇺🇸Cabrini Med Ctr, New York, New York, United States
A Study of Fluconazole in the Treatment of Cryptococcal Meningitis in Patients With AIDS
- Conditions
- Meningitis, CryptococcalHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Pfizer
- Registration Number
- NCT00002294
- Locations
- 🇺🇸
UCI Med Ctr, Orange, California, United States
🇺🇸Dr Robert Larsen, Los Angeles, California, United States
🇺🇸UCSD, San Diego, California, United States
Comparison of Fluconazole and Amphotericin B in the Treatment of Brain Infections in Patients With AIDS
- Conditions
- Meningitis, CryptococcalHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2011-03-14
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 330
- Registration Number
- NCT00001017
- Locations
- 🇺🇸
Beth Israel Deaconess - West Campus, Boston, Massachusetts, United States
🇺🇸SUNY - Stony Brook, Stony Brook, New York, United States
🇺🇸Duke Univ Med Ctr, Durham, North Carolina, United States
A Study of Azithromycin in HIV-Infected Patients
- Conditions
- Bacterial InfectionsHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 12
- Registration Number
- NCT00002344
- Locations
- 🇺🇸
Harris Laboratories Inc, Phoenix, Arizona, United States
Phase I Study of the Clinical Pharmacology of Azithromycin in Buffy Coat of HIV-Infected Subjects.
- Conditions
- Bacterial InfectionsHIV Infections
- First Posted Date
- 2001-08-31
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- Pfizer
- Registration Number
- NCT00002139
- Locations
- 🇺🇸
Ctr for Phase I Research, Wichita, Kansas, United States